Journal of Plastic, Reconstructive & Aesthetic Surgery
Volume 62, Issue 12 , Pages 1627-1635 , December 2009

Objective evidence for the use of polylactic acid implants in HIV-associated facial lipoatrophy using three-dimensional surface laser scanning and psychological assessment

  • J. Ong

      Affiliations

    • Department of Plastic and Reconstructive Surgery, The Royal Free Hospital Hampstead NHS Trust, Pond Street, London, NW3 2QG, UK
    • Corresponding Author InformationCorresponding author. Address: Department of Plastic and Reconstructive Surgery, The Royal Free Hospital Hampstead NHS Trust, Pond Street, London NW3 2QG, UK. Tel.: +44 7903 858 297.
  • ,
  • A. Clarke

      Affiliations

    • Department of Plastic and Reconstructive Surgery, The Royal Free Hospital Hampstead NHS Trust, Pond Street, London, NW3 2QG, UK
  • ,
  • P. White

      Affiliations

    • Department of Statistics, University of the West of England, Frenchay Campus, Coldharbour Lane, Bristol, BS16 1QY, UK
  • ,
  • M.A. Johnson

      Affiliations

    • Department of Infectious Diseases and HIV Medicine, The Royal Free Hospital Hampstead NHS Trust, Pond Street, London, NW3 2QG, UK
  • ,
  • S. Withey

      Affiliations

    • Department of Plastic and Reconstructive Surgery, The Royal Free Hospital Hampstead NHS Trust, Pond Street, London, NW3 2QG, UK
  • ,
  • P.E.M. Butler

      Affiliations

    • Department of Plastic and Reconstructive Surgery, The Royal Free Hospital Hampstead NHS Trust, Pond Street, London, NW3 2QG, UK

Received 19 March 2008 ,Accepted 17 July 2008.

References 

  1. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853–860
  2. Carr A. HIV lipodystrophy: risk factors, pathogenesis, diagnosis and management. Aids. 2003;17:S141–S148
  3. Carr A, Samaras K, Chisholm DJ, et al. Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. The Lancet. 1998;351:1881–1883
  4. Lichtenstein KA, Delaney KM, Armon C, et al. Incidence of and risk factors for lipoatrophy (abnormal fat loss) in ambulatory HIV-1-infected patients. J Acquir Immune Defic Syndr. 2003;32:48–56
  5. Barreiro P, Garcia-Benayas T, Soriano V, et al. Simplification of antiretroviral treatment–how to sustain success, reduce toxicity and ensure adherence avoiding PI use 1. AIDS Rev. 2002;4:233–241
  6. Spire B, Duran S, Souville M, et al. Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach. Soc Sci Med. 2002;54:1481–1496
  7. Nelson L, Stewart KJ. Plastic surgical options for HIV-associated lipodystrophy. J Plast Reconstr Aesthet Surg. 2008;61:359–365
  8. Gogolewski S, Jovanovic M, Perren SM, et al. Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA). J Biomed Mater Res. 1993;27:1135–1148
  9. Bush K, Antonyshyn O. Three-dimensional facial anthropometry using a laser surface scanner: validation of the technique. Plast Reconstr Surg. 1996;98:226–235
  10. Benn P, Ruff C, Cartledge J, et al. Overcoming subjectivity in assessing facial lipoatrophy: is there a role for three-dimensional laser scans?. HIV Med. 2003;4:325–331
  11. Aung SC, Ngim RCK, Lee ST. Evaluation of the laser scanner as a surface measuring tool and its accuracy compared with direct facial anthropometric measurements. Br J Plast Surg. 1995;48:551–558
  12. Lichtenstein KA, Ward DJ, Moorman AC, et al. Clinical assessment of HIV-associated lipodystrophy in an ambulatory population. Aids. 2001;15:1389–1398
  13. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–370
  14. Rosenberg M. Society and the adolescent self-image. Wesleyan University Press; 1989;
  15. Harris DL, Carr AT. The Derriford Appearance Scale (DAS59): a new psychometric scale for the evaluation of patients with disfigurements and aesthetic problems of appearance. Br J Plast Surg. 2001;54:216–222
  16. Chaffin WW, Rhiel SG. The effect of skewness and kurtosis on the one-sample T test and the impact of knowledge of the population standard deviation. J Stat Comput Simulation. 1993;46:79–90
  17. Kirk R. Procedures for the behavioural sciences. International Thompson Publishing; 1995;
  18. Stricker G, Clifford E, Cohen LK, et al. Psychosocial aspects of craniofacial disfigurement. A “State of the Art” assessment conducted by the Craniofacial Anomalies Program Branch, The National Institute of Dental Research. Am J Orthod. 1979;76:410–422
  19. Harcourt DM, Rumsey NJ, Ambler NR, et al. The psychological effect of mastectomy with or without breast reconstruction: a prospective, multicenter study. Plast Reconstr Surg. 2003;111:1060–1068
  20. Chandra PS, Deepthivarma S, Jairam KR, et al. Relationship of psychological morbidity and quality of life to illness-related disclosure among HIV-infected persons. J Psychosom Res. 2003;54:199–203
  21. Rosenthal R, Rosnow RL. Essentials of behavioural research: methods and data analysis. 3rd ed.. McGraw Hill Higher Education; 2008;

PII: S1748-6815(08)00886-3

doi: 10.1016/j.bjps.2008.07.046

Journal of Plastic, Reconstructive & Aesthetic Surgery
Volume 62, Issue 12 , Pages 1627-1635 , December 2009